Skip to main content
logo
Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
23.45
+0.71 (3.12%)
May 5, 2026, 4:00 PM EDT - Market closed

Amphastar Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,0441,2221,7682,9731,3481,111
Market Cap Growth
-6.13%-30.86%-40.53%120.54%21.31%16.35%
Enterprise Value
1,410937.371,5443,3331,2671,072
Last Close Price
23.4526.7837.1361.8528.0223.29
PE Ratio
11.4213.1912.1323.7916.1018.63
Forward PE
7.147.789.4220.7716.2916.96
PEG Ratio
1.657.010.991.070.860.89
PS Ratio
1.441.702.424.612.702.54
PB Ratio
1.32--4.652.552.49
P/TBV Ratio
---5.132.782.60
P/FCF Ratio
8.5510.0810.2620.4620.6915.75
P/OCF Ratio
6.647.838.2916.2015.1211.34
EV/Sales Ratio
1.961.302.115.172.542.45
EV/EBITDA Ratio
6.404.765.9814.189.5811.51
EV/EBIT Ratio
8.626.687.5216.9211.7815.34
EV/FCF Ratio
11.637.738.9622.9419.4415.20
Debt / Equity Ratio
---0.970.180.22
Debt / EBITDA Ratio
---2.650.781.12
Debt / FCF Ratio
---4.291.581.48
Net Debt / Equity Ratio
---0.57-0.14-0.08
Net Debt / EBITDA Ratio
-1.45-1.45-0.871.55-0.57-0.37
Net Debt / FCF Ratio
-2.35-2.35-1.302.51-1.16-0.48
Asset Turnover
0.450.450.470.570.710.67
Inventory Turnover
2.202.202.762.802.552.51
Quick Ratio
3.003.002.171.662.812.10
Current Ratio
4.284.283.202.173.993.06
Return on Equity (ROE)
--50.07%23.89%19.00%14.20%
Return on Assets (ROA)
6.95%6.95%11.22%14.23%12.13%8.10%
Return on Invested Capital (ROIC)
9.31%9.31%15.54%21.18%18.58%12.11%
Return on Capital Employed (ROCE)
9.71%9.71%15.23%20.36%17.70%12.86%
Earnings Yield
9.47%7.58%8.24%4.20%6.21%5.37%
FCF Yield
11.70%9.92%9.75%4.89%4.83%6.35%
Buyback Yield / Dilution
7.38%7.38%1.78%-1.09%-5.31%-1.34%
Total Shareholder Return
7.38%7.38%1.78%-1.09%-5.31%-1.34%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q